Home

Samrat S. Khichi

CIK 1612227 · EVP, CPO and General Counsel · last filed 2026-04-02

Samrat S. Khichi is an EVP, CPO and General Counsel who has filed 39 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for CVS, was dated Apr 2, 2026. Across all open-market trades the lifetime net is −$9.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.7M across reported positions. 23 SEC filings were submitted jointly with DICKINSON & CO BECTON.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.69M

Companies

3

Total Filings

39

Lifetime Open-Market Net

-$9.04M

Filer Profile

Reported Address
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET, NJ 08873
Related Filers
DICKINSON & CO BECTON — 23 joint filings, latest 2023-04-21
BARD C R INC /NJ/ — 10 joint filings, latest 2018-01-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CVS EVP, CPO and General Counsel 38,139 $96.74 $3.69M $0 8 2026-04-02
BECTON DICKINSON & CO (BDXB) Delisted EVP and General Counsel 9,251 $48.16 $445.5K -$4.29M 9 2023-01-05
BECTON DICKINSON & CO (BDXA) Delisted EVP and General Counsel 9,611 — — -$4.75M 11 2020-03-17

Recent Filings

39 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-02 CVS Mixed +8,990 $643.3K EDGAR
2026-03-02 CVS Tax (F) −7,886 -$627.7K EDGAR
2025-04-03 CVS Mixed +14,633 $994.8K EDGAR
2025-03-03 CVS Tax (F) −5,604 -$368.3K EDGAR
2024-04-03 CVS Grant (A) +12,569 $0 EDGAR
2024-03-01 CVS Tax (F) −6,210 -$466.9K EDGAR
2023-04-21 BDX Notice (144) −671 -$175.7K EDGAR
2023-04-17 BDX Notice (144) −755 -$193.3K EDGAR
2023-04-04 CVS Grant (A) — $0 EDGAR
2023-03-01 CVS Grant (A) +47,881 $4.00M EDGAR
Showing 1–10 of 39
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.